按产前与产后生长受限评估分类的32周前早产儿胎儿及新生儿结局
基于法国EPIPAGE 2人群前瞻性研究2011年24–31周单胎无畸形早产儿2919例,按产前疑似胎儿生长受限与产后小于胎龄儿(出生体重<同性别宫内标准第10百分位)分为4组。22.2%为疑似胎儿生长受限且小于胎龄儿,11.4%为非疑似但小于胎龄儿;两类小于胎龄儿的不良结局风险均升高,而疑似胎儿生长受限但非小于胎龄儿者风险未增加。
要点
- 产前与产后生长受限评估在14%的极早产儿中不一致。
- 无论产前是否疑似,小于胎龄儿的死亡与支气管肺发育不良风险均升高。
- 疑似胎儿生长受限但非小于胎龄儿的婴儿风险未增加。
核心结论
- 产前与产后对胎儿生长受限的评估在14%的极早产儿中不一致,在这些不一致病例中出生体重似乎是识别短期不良结局高风险婴儿更相关的参数。
研究设计与样本
- 基于法国EPIPAGE 2人群前瞻性研究2011年极早产儿数据,纳入2919例24–31周单胎无畸形婴儿,按产前是否疑似胎儿生长受限和/或产后是否为小于胎龄儿分为4组,校正母婴特征后估计围产期死亡与疾病的相对风险。
主要发现
- 22.2%的婴儿为疑似胎儿生长受限且小于胎龄儿,11.4%为非疑似胎儿生长受限但小于胎龄儿,3.0%为疑似胎儿生长受限但非小于胎龄儿,63.4%为非疑似胎儿生长受限且非小于胎龄儿。
- 与既非疑似胎儿生长受限又非小于胎龄儿的婴儿相比,疑似胎儿生长受限且小于胎龄儿组死胎或终止妊娠的校正相对风险为2.0(95%CI 1.6–2.5),非疑似胎儿生长受限但小于胎龄儿组为2.8(95%CI 2.2–3.4)。
- 与既非疑似胎儿生长受限又非小于胎龄儿的婴儿相比,疑似胎儿生长受限且小于胎龄儿组院内死亡的校正相对风险为2.8(95%CI 2.0–3.7),非疑似胎儿生长受限但小于胎龄儿组为2.0(95%CI 1.5–2.8)。
- 与既非疑似胎儿生长受限又非小于胎龄儿的婴儿相比,疑似胎儿生长受限且小于胎龄儿组支气管肺发育不良的校正相对风险为1.3(95%CI 1.2–1.4),非疑似胎儿生长受限但小于胎龄儿组为1.3(95%CI 1.1–1.4)。
- 严重脑损伤风险未见升高,疑似胎儿生长受限但非小于胎龄儿的婴儿风险未增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fetal growth restriction is defined using ultrasound parameters during pregnancy or as a low birthweight for gestational age after birth, but these definitions are not always concordant. OBJECTIVE: The purpose of this study was to investigate fetal and neonatal outcomes based on antenatal vs postnatal assessments of growth restriction. STUDY DESIGN: From the EPIPAGE 2 population-based prospective study of very preterm births in France in 2011, we included 2919 singleton nonanomalous infants 24-31 weeks gestational age. We constituted 4 groups based on whether the infant was suspected with fetal growth restriction during pregnancy and/or was small for gestational age with a birthweight <10th percentile of intrauterine norms by sex: 1) suspected with fetal growth restriction/small for gestational age 2) not suspected with fetal growth restriction/small for gestational age 3) suspected with fetal growth restriction/not small for gestational age and 4) not suspected with fetal growth restriction/not small for gestational age. We estimated relative risks of perinatal mortality and morbidity for these groups adjusting for maternal and neonatal characteristics. RESULTS: We found that 22.2% of infants were suspected with fetal growth restriction/small for gestational age, that 11.4% infants were not suspected with fetal growth restriction/small for gestational age, that 3.0% infants were suspected with fetal growth restriction/not small for gestational age, and that 63.4% infants were not suspected with fetal growth restriction/not small for gestational age. Compared with infants who were not suspected with fetal growth restriction/not small-for-gestational-age infants, small-for-gestational-age infants suspected and not suspected with fetal growth restriction had higher risks of stillbirth or termination of pregnancy (adjusted relative risk, 2.0 [95% confidence interval, 1.6-2.5] and adjusted relative risk, 2.8 [95% confidence interval, 2.2-3.4], respectively), in-hospital death (adjusted relative risk, 2.8 [95% confidence interval, 2.0-3.7] and adjusted relative risk, 2.0 [95% confidence interval, 1.5-2.8], respectively), and bronchopulmonary dysplasia (adjusted relative risk, 1.3 [95% confidence interval, 1.2-1.4] and adjusted relative risk, 1.3 [95% confidence interval, 1.1-1.4], respectively), but not severe brain lesions. Risks were not increased for infants suspected with fetal growth restriction but not small-for-gestational-age. CONCLUSION: Antenatal and postnatal assessments of fetal growth restriction were not concordant for 14% of very preterm infants. In these cases, birthweight appears to be the more relevant parameter for the identification of infants with higher risks of adverse short-term outcomes.
引用
- Monier I, Ancel PY, Ego A, et al. Fetal and neonatal outcomes of preterm infants born before 32 weeks of gestation according to antenatal vs postnatal assessments of restricted growth. Am J Obstet Gynecol. 2017. PMID: 28188770. doi:10.1016/j.ajog.2017.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。